AK
Aditya Kumar Mishra
About Aditya Kumar Mishra
Data last updated:
Aditya Kumar Mishra has 14 years in corporate governance. Holds Director role. Currently with 3 companies, including Respion Healthcare Private Limited and Respisleep Healthcare Private Limited. Formerly with 1 company, such as Aps Commtrade Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Respion Healthcare Private Limited U74999OR2021PTC037064 | Director | 22 Jul 2021 | 2021 | Active |
| Respisleep Healthcare Private Limited U85100OR2018PTC029278 | Director | 08 Aug 2018 | 2018 | Active |
| Respion Healthcare At Home Private Limited U87100OD2023PTC043021 | Director | 29 Jun 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Aps Commtrade Private Limited U51300OR2012PTC015445 | Director | 28 May 2012 | 2012 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aditya Kumar Mishra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aditya Kumar Mishra
Aditya Kumar Mishra has 14 years in corporate governance. Holds Director role. Currently with 3 companies, including Respion Healthcare Private Limited and Respisleep Healthcare Private Limited. Formerly with 1 company, such as Aps Commtrade Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Aditya Kumar Mishra is associated with 3 companies as Director.
Aditya Kumar Mishra has expertise in Healthcare, General Business.
Aditya Kumar Mishra has 14 years in corporate governance.